MyAverix Finance
NS · Pharmaceuticals
Innova Captab Ltd (INNOVACAP)
Pharmaceuticals & Biotechnology
Innova Captab Ltd (INNOVACAP) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $53.91B, P/E ratio is 64.39, net margin is 7.8%, dividend yield is 0.21%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for INNOVACAP
Innova Captab Ltd (INNOVACAP) — FAQ
What is Innova Captab Ltd's market cap?
Innova Captab Ltd (INNOVACAP) has a reported market cap of $53.91B (data as of 2026-07-10).
What is INNOVACAP's P/E ratio?
The price-to-earnings (P/E) ratio for Innova Captab Ltd (INNOVACAP) is 64.39 (data as of 2026-07-10).
Does Innova Captab Ltd pay a dividend?
Innova Captab Ltd (INNOVACAP) shows a reported dividend yield of 0.21%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Innova Captab Ltd in?
Innova Captab Ltd (INNOVACAP) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is INNOVACAP listed on?
INNOVACAP is listed on NS.
What is Innova Captab Ltd's net margin?
Innova Captab Ltd (INNOVACAP) reports a net margin of 7.8% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.